A prolonged complete response in a patient with BRAF-mutated melanoma stage IV treated with the MEK1/2 inhibitor selumetinib (AZD6244)
| Image |  |
|---|---|
| Description | scientific article published on 01 August 2012 |
| Author/s |
author: Willeke A.M. Blokx |
| Publication date | August 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |